FDA Approves Updated Moderna, Pfizer COVID-19 Boosters

RALEIGH, N.C. — On Wednesday, the FDA authorized both the Moderna and Pfizer-BioNTech bivalent COVID-19 booster dose, which protects against all strains of COVID.

The FDA stated that the new boosters “are expected to provide increased protection against the currently circulating omicron variant.”

As a result of the FDA’s action, the original booster dose, which contains one strain of the virus, is no longer authorized for people 12 and older, according to a news release.

Health officials say the original booster is still authorized for children ages 5-11 years old.

The CDC must recommend both the Moderna and Pfizer-BioNTech bivalent COVID-19 booster dose for people 12 and over before vaccinations can begin.

Officials say that means that booster doses for people 12 and older are not currently available, but they will be available next week pending the CDC’s recommendation.

North Carolina has nearly 500,000 doses arriving in state over the next two weeks, with 229,000 of those doses going to federal pharmacies (CVS, Walgreens, etc.), according to a news release.

Officials expect that the new booster shots for people 12 and over will be available by Tuesday, depending on the CDC recommendation.